Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: J Cell Physiol. 2018 Feb 27;233(8):5684–5695. doi: 10.1002/jcp.26421

Table 1.

Advantages and disadvantages of different gene therapy vectors

Vector Advantages Disadvantages
Viral vectors
Adeno-associated Viruses Low immunogenicity
Stable transgene expression
Small transgene insert capacity (~4.8 kb)
Complex process of vector production
Adenovirus Biologically safe
Large transgene insert capacity (~38 kb)
High immunogenicity
Short term gene expression
Herpes simplex virus Large transgene insert capacity (~150 kb) Immunogenicity
Lentivirus Infect both dividing and nondividing cells
Long term stable expression of transgene
Low immunogenicity
Insertional mutagenesis
Measles Virus Better safety profile Wild type virus is immunosuppressive
Many adults are immune
Retrovirus Infect only dividing cells
Stable transgene expression
Risk of insertion
Small transgene insert capacity
Immunogenicity, low efficiency in vivo
Vaccinia virus Large insert capacity
Better safety profile
High immunogenicity
Replication in skin lesion
Vesicular Stomatitis virus Selective replication competent in tumor cells High immunogenicity
Animal pathogen-safety concern
Non viral vectors
Plasmid/Naked DNA Easy to engineer
Low immunogenicity
Rapid clearance, low transfection efficiency
Cationic liposomes Large gene carrying capacity
Better accumulation of nanoparticle in tumors
Low transfection efficacy and inflammatory toxicity